title: Whither tobacco product regulation?
abstract: Despite decades of industry innovation and regulatory efforts, the harmfulness of conventional cigarettes has not changed. There are several pitfalls in this area, including the long time lag before health impacts of product regulatory changes become apparent, the danger of consumers deriving false reassurance of lesser harm in the interim period, the lack of relevant expertise and the lack of an internationally agreed and evidence-based strategic approach. Articles 9 and 10 of the Framework Convention on Tobacco Control provide the potential for such a global strategy, and knowledge and research has increased significantly over recent years. However, there are huge opportunity costs in implementing product disclosure and regulatory strategies: most national regulators have very limited human and financial resources, which should be focused on other evidence-based tobacco control interventions. We believe therefore that it is now time to abandon the notion of safe or safer cigarettes while moving consumers towards cleaner nicotine products as soon as possible. In parallel to this, we recommend a number of other strategies be implemented including: reducing the appeal of all tobacco products, forbidding new tobacco products or brand variants being marketed without evidence of reduced harm, appeal or addictiveness, and developing a tobacco industry resourced, but industry independent, Framework Convention on Tobacco Control global repository to assist national regulators in understanding and regulating the products on their markets.
authors.affiliation: University of Nottingham, Nottingham, UK. ann.mcneill@nottingham.ac.uk
authors.forename: Ann
authors.initials: A
authors.lastname: McNeill
authors.forename: David
authors.initials: D
authors.lastname: Hammond
authors.forename: Coral
authors.initials: C
authors.lastname: Gartner
mesh_terms: D003257:Consumer Product Safety / Q000331:legislation & jurisprudence; D040261:Harm Reduction; D006293:Health Promotion / Q000379:methods; D006801:Humans; D012907:Smoking / Q000009:adverse effects / Q000331:legislation & jurisprudence*; D016540:Smoking Cessation / Q000379:methods; D000074606:Smoking Prevention; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D014029:Tobacco Use Disorder / Q000517:prevention & control; D014030:Tobacco, Smokeless / Q000009:adverse effects